These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 34909721)

  • 1. SB206, a Nitric Oxide-Releasing Topical Medication, Induces the Beginning of the End Sign and Molluscum Clearance.
    Maeda-Chubachi T; Hebert D; Messersmith E; Siegfried EC
    JID Innov; 2021 Sep; 1(3):100019. PubMed ID: 34909721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and tolerability of an investigational nitric oxide-releasing topical gel in patients with molluscum contagiosum: A randomized clinical trial.
    Hebert AA; Siegfried EC; Durham T; de León EN; Reams T; Messersmith E; Maeda-Chubachi T
    J Am Acad Dermatol; 2020 Apr; 82(4):887-894. PubMed ID: 31586600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and Safety of Topical Nitric Oxide-Releasing Berdazimer Gel in Patients With Molluscum Contagiosum: A Phase 3 Randomized Clinical Trial.
    Browning JC; Enloe C; Cartwright M; Hebert A; Paller AS; Hebert D; Kowalewski EK; Maeda-Chubachi T
    JAMA Dermatol; 2022 Aug; 158(8):871-878. PubMed ID: 35830173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and Efficacy of VP-102, a Proprietary, Drug-Device Combination Product Containing Cantharidin, 0.7% (w/v), in Children and Adults With Molluscum Contagiosum: Two Phase 3 Randomized Clinical Trials.
    Eichenfield LF; McFalda W; Brabec B; Siegfried E; Kwong P; McBride M; Rieger J; Willson C; Davidson M; Burnett P
    JAMA Dermatol; 2020 Dec; 156(12):1315-1323. PubMed ID: 32965495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Berdazimer gel for molluscum contagiosum in patients with atopic dermatitis.
    Paller AS; Green LJ; Silverberg N; Stripling S; Cartwright M; Enloe C; Wells N; Kowalewski EK; Maeda-Chubachi T
    Pediatr Dermatol; 2024; 41(3):438-444. PubMed ID: 38413239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Berdazimer gel for molluscum contagiosum: An integrated analysis of 3 randomized controlled trials.
    Sugarman JL; Hebert A; Browning JC; Paller AS; Stripling S; Green LJ; Cartwright M; Enloe C; Wells N; Maeda-Chubachi T
    J Am Acad Dermatol; 2024 Feb; 90(2):299-308. PubMed ID: 37804936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The molluscum contagiosum BOTE sign-Infected or inflamed?
    Gross I; Ben Nachum N; Molho-Pessach V; Weiser G; Oster Y; Engelhard D; Megged O; Hashavya S
    Pediatr Dermatol; 2020 May; 37(3):476-479. PubMed ID: 32115769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Phase 2 Open-Label Study to Evaluate VP-102 for the Treatment of Molluscum Contagiosum.
    Niazi S; Brabec B; Anschutz L; Willson C; Davidson M; Burnett P
    J Drugs Dermatol; 2021 Jan; 20(1):70-75. PubMed ID: 33400412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and efficacy of topical nitric oxide-releasing berdazimer gel for molluscum contagiosum clearance: A systematic review and meta-analysis of randomized controlled trials.
    Pera Calvi I; R Marques I; Cruz SA; Mesquita YLL; Padrao EMH; Souza RM; Brown A; Caçador DGV; Poppe LM; Lopes Almeida Gomes L
    Pediatr Dermatol; 2023; 40(6):1060-1063. PubMed ID: 37721050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Phase 2 Controlled Study of SB206, a Topical Nitric Oxide-Releasing Drug for Extragenital Wart Treatment.
    Tyring SK; Rosen T; Berman B; Stasko N; Durham T; Maeda-Chubachi T
    J Drugs Dermatol; 2018 Oct; 17(10):1100-1105. PubMed ID: 30365591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic Profile, Safety, and Tolerability of Topical Berdazimer Gel, 10.3% in Patients With Molluscum Contagiosum.
    Cartwright M; Enloe C; Stripling S; Maeda-Chubachi T
    J Drugs Dermatol; 2022 Oct; 21(10):1104-1110. PubMed ID: 36219053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molluscum BOTE sign: a predictor of imminent resolution.
    Butala N; Siegfried E; Weissler A
    Pediatrics; 2013 May; 131(5):e1650-3. PubMed ID: 23545377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Granuloma Annulare-Like Id Reaction to Inflamed Molluscum Contagiosum: A Case Report.
    Jicha KI; Nieman EL; Morrell DS
    Clin Med Insights Pediatr; 2023; 17():11795565231194819. PubMed ID: 37654602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pooled Results of Two Randomized Phase III Trials Evaluating VP-102, a Drug-Device Combination Product Containing Cantharidin 0.7% (w/v) for the Treatment of Molluscum Contagiosum.
    Eichenfield LF; Siegfried E; Kwong P; McBride M; Rieger J; Glover D; Willson C; Davidson M; Burnett P; Olivadoti M
    Am J Clin Dermatol; 2021 Mar; 22(2):257-265. PubMed ID: 33599960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dermoscopic Features of Giant Molluscum Contagiosum in a Patient with Acquired Immunodeficiency Syndrome.
    Sławińska M; Hlebowicz M; Iżycka-Świeszewska E; Sikorska M; Sokołowska-Wojdyło M; Smiatacz T; Gesing M; Nowicki RJ; Sobjanek M
    Acta Dermatovenerol Croat; 2020 Dec; 28(7):233-235. PubMed ID: 33834996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Patient-Centered Perspective of Molluscum Contagiosum as Reported by B-SIMPLE4 Clinical Trial Patients and Caregivers: Global Impression of Change and Exit Interview Substudy Results.
    Browning JC; Cartwright M; Thorla I; Martin SA; Olayinka-Amao O; Maeda-Chubachi T
    Am J Clin Dermatol; 2023 Jan; 24(1):119-133. PubMed ID: 36287306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SB206, a New Topical Nitric Oxide-Releasing Drug on the Horizon for the Treatment of Molluscum Contagiosum and External Anogenital Warts.
    Belmesk L; Litvinov IV; Netchiporouk E
    J Cutan Med Surg; 2020; 24(4):412-413. PubMed ID: 32400176
    [No Abstract]   [Full Text] [Related]  

  • 18. New Developing Treatments for Molluscum Contagiosum.
    Lacarrubba F; Micali G; Trecarichi AC; Quattrocchi E; Monfrecola G; Verzì AE
    Dermatol Ther (Heidelb); 2022 Dec; 12(12):2669-2678. PubMed ID: 36239905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and efficacy of topical cantharidin for the treatment of pediatric molluscum contagiosum: a prospective, randomized, double-blind, placebo-controlled pilot trial.
    Guzman AK; Schairer DO; Garelik JL; Cohen SR
    Int J Dermatol; 2018 Aug; 57(8):1001-1006. PubMed ID: 29904968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of imiquimod cream 5% for treating childhood molluscum contagiosum in a double-blind, randomized pilot trial.
    Theos AU; Cummins R; Silverberg NB; Paller AS
    Cutis; 2004 Aug; 74(2):134-8, 141-2. PubMed ID: 15379366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.